Results 31 to 40 of about 1,205,764 (269)
Amisulpride-induced late-onset rabbit syndrome: Case report and literature review
Introduction Amisulpride is an atypical antipsychotic. Rabbit syndrome(RS) may be seen after antipsychotics use a few days or long‐term application. RS occurs after more frequent typical antipsychotics and also in rare cases atypical antipsychotics.Its ...
I. Gundogmus +4 more
doaj +1 more source
Movement disorders encompass a broad spectrum of neurological conditions characterized by either excessive (hyperkinetic) or reduced (hypokinetic) movement.
Osamu Hasegawa
doaj +1 more source
Anaesthetic Management of a High-risk Patient with Chronic Post-stroke Chorea undergoing Forearm Surgery: A Case Report [PDF]
Movement disorders such as chorea represent a significant challenge in anaesthetic practice due to involuntary movements, airway concerns, and associated co-morbidities, particularly when secondary to Cerebrovascular Accidents (CVA).
Nikita Sareen +3 more
doaj +1 more source
Chorea-acanthocytosis (ChAc) is a rare, neurodegenerative disorder caused by mutations in the VPS13A gene. In this article, we report on a 32-year-old man diagnosed with ChAc, with involuntary movements of the mouth and trunk, drooling of the mouth ...
Yan Xu +6 more
doaj +1 more source
Since electrophysiological correlates of l-dopa-induced dyskinesia (LID) are almost unknown, changes of striatal dopamine (DA) transmission and electrophysiological activity of the substantia nigra pars reticulata (SNr) were recorded before and after ...
Wassilios Meissner +10 more
doaj +1 more source
This study aimed to determine the long-term quality of life (QoL) in hemifacial spasm (HFS) patients after treating with Abo-botulinum toxin A (Abo-BTX).
Subsai Kongsaengdao +2 more
doaj +1 more source
Abnormal Involuntary Movement Scale in Tardive Dyskinesia:Minimal Clinically Important Difference [PDF]
BackgroundA minimal clinically important difference has not been established for the Abnormal Involuntary Movement Scale in patients with tardive dyskinesia.
NC DOCKS at East Carolina University +1 more
core +3 more sources
Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats
The short duration of effect of levodopa is linked to pulsatile stimulation of striatal dopamine receptors and dyskinesia induction. However, the recent introduction of intraduodenal (i.d.) infusions and novel oral controlled release formulations of l ...
Peter Jenner +14 more
core +1 more source
Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias +3 more
wiley +1 more source
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong +10 more
wiley +1 more source

